Not Medicare Enrolled
Dr. Van Rana, 09221980
Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rana
Dr. Van Rana is a medical oncology specialist in Fort Myers, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rana performed 75,835 Medicare services across 3,005 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rana received a total of $8,242 from 76 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rana is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in FL
$8,242 industry payments
Medicare Practice Summary
Medicare Utilization ↗75,835
Medicare services
Top 29% in FL for medical oncology
3,005
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,991 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 17,850 | $0 | $4 |
| Azacitidine chemotherapy injection | 17,100 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 9,240 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 8,400 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 6,090 | $6 | $23 |
| Iron sucrose injection (Venofer) | 4,500 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 2,580 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 1,690 | $1 | $5 |
| Immune globulin infusion (Gammagard) | 1,640 | $36 | $108 |
| Complete blood count (CBC) with differential | 1,333 | $8 | $29 |
| Blood draw (venipuncture) | 1,293 | $8 | $9 |
| Dexamethasone injection (steroid) | 854 | $0 | $3 |
| Office visit, established patient (30-39 min) | 612 | $99 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 450 | $1 | $28 |
| Drug injection, under skin or into muscle | 443 | $11 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 170 | $104 | $378 |
| Injection of additional new drug or substance into vein | 156 | $12 | $61 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 144 | $18 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 128 | $51 | $189 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 113 | $57 | $206 |
| Anti-nausea injection (ondansetron/Zofran) | 112 | $0 | $9 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 112 | $1 | $6 |
| Office visit, established patient (20-29 min) | 109 | $67 | $239 |
| Infusion, normal saline solution , 1000 cc | 83 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 70 | $10 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 69 | $1 | $3 |
| Infusion into a vein for hydration, 31-60 minutes | 67 | $25 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 56 | $23 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 47 | $16 | $56 |
| Administration of chemotherapy into vein, each additional hour | 47 | $22 | $79 |
| Prothrombin time test (blood clotting) | 42 | $4 | $15 |
| New patient office visit (45-59 min) | 32 | $129 | $453 |
| Administration of additional new drug or substance into vein, 1 hour or less | 30 | $52 | $178 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 29 | $3 | $11 |
| Drawing of blood for a medical problem | 27 | $69 | $277 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $24 | $89 |
| Injection of drug or substance into vein | 23 | $30 | $156 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 21 | $136 | $467 |
| Office visit, established patient, complex (40-54 min) | 18 | $137 | $474 |
| Red blood count, automated test | 16 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 15 | $173 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.3% high complexity
68.9% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,242
Total received (2018-2024)
Avg $1,177/year across 7 years
Top 48% in FL for medical oncology
76
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,780 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$462 (5.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$32
2023
$1,597
2022
$1,770
2021
$1,100
2020
$1,202
2019
$1,310
2018
$1,232
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$600
Janssen Biotech, Inc.
$461
Celgene Corporation
$446
GENZYME CORPORATION
$441
Exelixis Inc.
$389
Amgen Inc.
$386
Spectrum Pharmaceuticals Inc.
$372
Merck Sharp & Dohme Corporation
$369
Astellas Pharma US Inc
$353
Novartis Pharmaceuticals Corporation
$344
Lilly USA, LLC
$343
Merck Sharp & Dohme LLC
$337
Incyte Corporation
$293
Genentech USA, Inc.
$276
PFIZER INC.
$193
Pharmacyclics LLC, An AbbVie Company
$187
Gilead Sciences, Inc.
$181
AstraZeneca Pharmaceuticals LP
$159
Daiichi Sankyo Inc.
$142
Regeneron Healthcare Solutions, Inc.
$135
Seagen Inc.
$121
ARRAY BIOPHARMA INC
$113
Medtronic MiniMed, Inc.
$78
Puma Biotechnology, Inc.
$75
BeiGene USA, Inc.
$74
CTI BioPharma Corp.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$58
Kite Pharma, Inc.
$57
Deciphera Pharmaceuticals Inc.
$51
EMD Serono, Inc.
$50
PharmaEssentia USA Corporation
$48
Acrotech Biopharma LLC
$46
Sun Pharmaceutical Industries Inc.
$40
MorphoSys, US Inc.
$40
CSL Behring
$38
Helsinn Therapeutics (U.S.), Inc.
$38
ABBVIE INC.
$38
NanoString Technologies, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$36
Rigel Pharmaceuticals, Inc.
$35
TerSera Therapeutics LLC
$33
SOBI, INC
$31
Alnylam Pharmaceuticals Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Secura Bio, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
Agios Pharmaceuticals, Inc.
$28
Dendreon Pharmaceuticals LLC
$25
Jazz Pharmaceuticals Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$23
AbbVie, Inc.
$23
EISAI INC.
$23
AbbVie Inc.
$22
Catalyst Pharmaceuticals, Inc.
$22
Emmaus Medical, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Kyowa Kirin, Inc.
$19
Epizyme, Inc.,
$18
Stemline Therapeutics Inc.
$18
Eisai Inc.
$18
Sobi, Inc
$18
Acceleron Pharma, Inc.
$17
AVEO Pharmaceuticals, Inc.
$17
TESARO, Inc.
$16
Aveo Pharmaceuticals, Inc.
$15
Sumitomo Pharma America, Inc.
$13
Alexion Pharmaceuticals, Inc.
$13
Myovant Sciences Inc.
$12
Blueprint Medicines Corporation
$11
Sysmex America, Inc.
$11
Partner Therapeutics, Inc.
$11
GE HEALTHCARE
$9
Fortovia Therapeutics, Inc.
$9
Janssen Pharmaceuticals, Inc
$4
Veracyte, Inc.
$1
Top 3 companies account for 18.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CERDELGA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · Erleada · FARYDAK · FIRDAPSE · FOTIVDA · Farydak · Folotyn · GAZYVA · GILOTRIF · HEMADY · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LUMAKRAS · LYNPARZA · Lenvima · Leukine · MONJUVI · MVASI · Minimed 670G System · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · SANDOSTATIN · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XN Series · XOSPATA · XTANDI · YONSA · YONSA (abiraterone acetate) · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zuplenz
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $11 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
11
Per 100K population
1.4
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rana is a mixed practice specialist, with above-average Medicare volume (top 29% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rana experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rana performed 17,850 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rana receive payments from pharmaceutical companies?
Yes. Dr. Rana received a total of $8,242 from 76 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rana's costs compare to other medical oncologists in Fort Myers?
Dr. Rana's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fort Myers
Browse medical oncologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology